{
    "organizations": [],
    "uuid": "3729c067955d5935044ae89247836b71fdea7e0c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pfizer-qtrly-worldwide-total-lyric/brief-pfizer-qtrly-worldwide-total-lyrica-revenue-1131-mln-idUSFWN1S806U",
    "ord_in_thread": 0,
    "title": "BRIEF-Pfizer Qtrly Worldwide Total Lyrica Revenue $1,131 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1 (Reuters) - Pfizer Inc:\n* PFIZER INC - QTRLY WORLDWIDE TOTAL LYRICA REVENUE $1,131 MILLION VERSUS $1,131 MILLION\n* PFIZER INC - QTRLY WORLDWIDE IBRANCE REVENUE $933 MILLION VERSUS $679 MILLION\n* PFIZER INC - QTRLY WORLDWIDE LIPITOR REVENUE $511 MILLION VERSUS $404 MILLION\n* PFIZER INC - QTRLY WORLDWIDE PREVNAR FAMILY REVENUE $1,380 MILLION VERSUS $1,392 MILLION Source text: ( bit.ly/2FvTnyf ) Further company coverage:\n ",
    "published": "2018-05-01T19:06:00.000+03:00",
    "crawled": "2018-05-02T16:22:50.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "pfizer",
        "inc",
        "pfizer",
        "inc",
        "qtrly",
        "worldwide",
        "total",
        "lyrica",
        "revenue",
        "million",
        "versus",
        "million",
        "pfizer",
        "inc",
        "qtrly",
        "worldwide",
        "ibrance",
        "revenue",
        "million",
        "versus",
        "million",
        "pfizer",
        "inc",
        "qtrly",
        "worldwide",
        "lipitor",
        "revenue",
        "million",
        "versus",
        "million",
        "pfizer",
        "inc",
        "qtrly",
        "worldwide",
        "prevnar",
        "family",
        "revenue",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "company",
        "coverage"
    ]
}